An aging population is demanding better treatment in an effort to live longer lives (I'm beginning to count myself among that population). As we've detailed in these pages over the years, there's incredible new innovation in gene therapies, immuno-oncology, precision medicine, machine-learning drug discovery, and treatments for unmet medical needs, such as Geographic Apathy.

For 40 years, ImmunoGen has been targeting a better life for people with cancer, as they believe it’s not enough to disrupt the progress of the disease, they want to keep cancer from disrupting someone's life.